{
    "clinical_study": {
        "@rank": "23379", 
        "arm_group": [
            {
                "arm_group_label": "Tailored intervention", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive a combined behavioral and pharmacological intervention. The behavioral component will consist of a six-session cognitive behavioral telephone intervention combined with supplemental treatment modules to address common issues (symptoms of depression, weight gain, risky alcohol use) associated with cigarette smoking based on eligibility and preference."
            }, 
            {
                "arm_group_label": "Enhanced standard of care", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants assigned to the enhanced standard of care condition will receive referral to their state tobacco quitline along with pharmacotherapy to assist with smoking cessation."
            }
        ], 
        "brief_summary": {
            "textblock": "The project is designed to examine the effectiveness of strategies to increase access to\n      treatment for tobacco use and dependence among rural Veteran smokers.  In addition, it will\n      examine whether tailored treatment that is designed to address common comorbid conditions\n      that are related to cigarette smoking enhances success with quitting relative to enhanced\n      standard of care.  The investigators hypothesize that participants assigned to the tailored\n      tobacco cessation intervention will report greater cessation rates at six months. The\n      investigators also anticipate more favorable outcomes on measures of depressive symptoms,\n      alcohol use, and body weight."
        }, 
        "brief_title": "Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Nicotine Dependence", 
            "Tobacco Use"
        ], 
        "condition_browse": {
            "mesh_term": "Tobacco Use Disorder"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Veteran status\n\n          -  18 + years of age\n\n          -  Smoke cigarettes on at least a daily basis\n\n          -  Receive primary care from the Iowa City VA Health Care System or an affiliated\n             Community-based Outpatient Clinic (CBOC)\n\n          -  Live in a non-metropolitan area (based on Rural-Urban Commuting Area Codes (RUCA)\n             codes)\n\n          -  Be willing to make an attempt to quit smoking in the next 30 days\n\n          -  Be capable of providing informed consent\n\n          -  Have access to a telephone (land line or cell phone)\n\n          -  Have a stable residence\n\n        Exclusion Criteria:\n\n          -  Planning to move within the next 12 months\n\n          -  Presence of a terminal illness\n\n          -  Pregnancy\n\n          -  Unstable psychiatric disorder (e.g., acute psychosis)\n\n          -  Currently pregnant\n\n          -  Incarcerated\n\n          -  Institutionalized"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01892813", 
            "org_study_id": "N32-FY13Q2-S0-P00723"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Nicotine replacement therapy - Transdermal nicotine patch", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Nicotine replacement therapy - Nicotine gum", 
                "intervention_type": "Drug", 
                "other_name": "Nicotine polacrilix"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Nicotine replacement therapy - Nicotine lozenge", 
                "intervention_type": "Drug", 
                "other_name": "Nicotine polacrilix"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Bupropion", 
                "intervention_type": "Drug", 
                "other_name": "Zyban"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Varenicline", 
                "intervention_type": "Drug", 
                "other_name": "Chantix"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Combination pharmacotherapy - Transdermal nicotine patch + nicotine gum", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Combination pharmacotherapy - Transdermal nicotine patch + nicotine lozenge", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Tailored intervention", 
                    "Enhanced standard of care"
                ], 
                "description": "Medication selection will be determined based on individual participant preferences, medical history, and contraindications.", 
                "intervention_name": "Combination pharmacotherapy - Transdermal nicotine patch + bupropion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Enhanced standard of care", 
                "description": "Participants assigned to this condition will receive a referral to their state tobacco quitline. The specific behavioral treatment that is provided will differ slightly depending upon the services available through the participant's state of residence.", 
                "intervention_name": "Tobacco quitline referral", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Tailored intervention", 
                "description": "Participants will receive a standard six session cognitive behavioral intervention for smoking cessation combined with supplemental treatment modules based on individual need and preference.", 
                "intervention_name": "Tailored behavioral intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Tailored intervention", 
                "description": "Participants engaging in risky alcohol use may receive this six-session telephone-based behavioral intervention for reducing alcohol use.", 
                "intervention_name": "Alcohol use risk reduction", 
                "intervention_type": "Behavioral", 
                "other_name": "Harm reduction"
            }, 
            {
                "arm_group_label": "Tailored intervention", 
                "description": "Participants with elevated depressive symptoms may receive this six-session telephone-based behavioral activation intervention.", 
                "intervention_name": "Behavioral activation for depressive symptoms", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Tailored intervention", 
                "description": "Participants with concerns about gaining weight after quitting smoking may receive this six-session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.", 
                "intervention_name": "Behavioral management of postcessation weight gain", 
                "intervention_type": "Behavioral", 
                "other_name": "Weight management"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ethanol", 
                "Nicotine polacrilex", 
                "Bupropion", 
                "Nicotine", 
                "Varenicline"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Nicotine dependence", 
            "Smoking cessation", 
            "Telehealth", 
            "Alcohol use", 
            "Depression", 
            "Body weight"
        ], 
        "lastchanged_date": "July 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Iowa City", 
                    "country": "United States", 
                    "state": "Iowa", 
                    "zip": "52246"
                }, 
                "name": "Iowa City VA Healthcare System"
            }, 
            "investigator": {
                "last_name": "Mark W. Vander Weg, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Tailored Tobacco Intervention", 
        "overall_contact": {
            "email": "mark.vanderweg@va.gov", 
            "last_name": "Mark W. Vander Weg, Ph.D.", 
            "phone": "319-338-0581", 
            "phone_ext": "7717"
        }, 
        "overall_contact_backup": {
            "email": "ashley.cozad@va.gov", 
            "last_name": "Ashley J. Cozad, M.P.H.", 
            "phone": "319-338-0581", 
            "phone_ext": "3537"
        }, 
        "overall_official": {
            "affiliation": "VRHRC-CR", 
            "last_name": "Mark W. Vander Weg, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At the six-month follow-up contact, participants will be questioned regarding self-reported tobacco use over the past seven and 30 days.", 
            "measure": "Tobacco use", 
            "safety_issue": "No", 
            "time_frame": "Six-month follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01892813"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Iowa", 
            "investigator_full_name": "Mark Vander Weg", 
            "investigator_title": "Associate Professor of Internal Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Alcohol use during the previous seven days will be assessed at the six month follow-up. Based on this information, several metrics of alcohol consumption will be obtained including: 1) average number of drinking days per week, 2) average number of drinks per drinking day, 3) number of drinks per week 4) number of heavy drinking days, and 5) maximum drinks consumed on a single occasion.", 
                "measure": "Alcohol use", 
                "safety_issue": "No", 
                "time_frame": "Six-month follow-up"
            }, 
            {
                "description": "Depressive symptoms will be assessed at the six-month follow-up using the Patient Health Questionnaire 9 (PHQ-9).", 
                "measure": "Depressive symptoms", 
                "safety_issue": "No", 
                "time_frame": "Six-month follow-up"
            }, 
            {
                "description": "Change in body weight will be assessed via self-report and chart review at the six-month follow-up.", 
                "measure": "Body weight", 
                "safety_issue": "No", 
                "time_frame": "Six-month follow-up"
            }, 
            {
                "description": "Physical activity will be assessed by self-report at the six-month follow-up visit using the Rapid Assessment of Physical Activity (RAPA).", 
                "measure": "Physical Activity", 
                "safety_issue": "No", 
                "time_frame": "Six-month follow-up"
            }, 
            {
                "description": "Self-reported dietary intake will be measured at six months using the Starting the Conversation - Diet questionnaire.", 
                "measure": "Dietary intake", 
                "safety_issue": "No", 
                "time_frame": "Six-month follow-up"
            }
        ], 
        "source": "University of Iowa", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "University of Iowa", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}